CN103520659A - Traditional Chinese medicine for treating cancer - Google Patents
Traditional Chinese medicine for treating cancer Download PDFInfo
- Publication number
- CN103520659A CN103520659A CN201310530442.2A CN201310530442A CN103520659A CN 103520659 A CN103520659 A CN 103520659A CN 201310530442 A CN201310530442 A CN 201310530442A CN 103520659 A CN103520659 A CN 103520659A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- patient
- chinese medicine
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides traditional Chinese medicine for treating cancer. The traditional Chinese medicine comprises rhizoma sparganii, subprostrate sophora, the root of red-rooted salvia, radix scrophulariae, the root of straight ladybell, codonopsis pilosula, radix angelicae, angelica sinensis, the root of common peony, curcuma aromatica, radix scutellariae, poria cocos, curcuma zedoary, thunberg fritillary, the seed of garden balsam, dandelions, cortex moutan, cinnabar, eupolyphaga, trogopterus dung, flos carthami, cordyceps sinensis, manis pentadactyla, elecampane, rhizoma corydalis, leeches, earthworm and platycodon grandiflorum. By taking the traditional Chinese medicine, the immunity of a patient can be improved, the capacity of human body leukocyte for killing cancer cells can be enhanced, and the effects of viscera benefiting, excitement tranquilizing and allaying, swelling and pain relieving, qi promoting, collateral obstruction removing, lump gradual reducing, patient pain relieving, life quality improving and service life prolonging are achieved. Through improvement of the immunity of the patient, the patient can remove cancer cells by the resistance of the patient. The effect of relapse preventing can be achieved after the patient is subjected to operation, radiotherapy and chemotherapy. Pain of a terminal cancer patient can be relieved if the patient takes the medicine, and the life of the patient can be prolonged. A good curative effect can be achieved if an early cancer patient takes the medicine.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of Chinese medicine for the treatment of cancer.
Background technology
Since entering 21 century, malignant tumor (cancer it has often been said) has become one of disease of serious harm human health, is called as the difficult medical problem of the incurable disease ，Shi world today.World Health Organization's report shows, the sickness rate of cancer and mortality rate are soaring year by year, and in the last thirty years, world's cancer morbidity is with the speed increase of average annual 3-5%, medicine or the method effect for the treatment of cancer are not ideal at present, and cancer has become first cause of the death of the mankind
.
Now, the treatment of cancer is mainly contained to doctor trained in Western medicine and the large class of the traditional Chinese medical science two, respectively have pluses and minuses, its Chinese and western medicine is mainly taked operative treatment, radiation cure (as gamma knife, x-ray cutter, Photon Knife), chemotherapy, interventional therapy etc.After the general excision of early-stage cancer, clinical cure be can obtain, but postoperative recurrence and transfer importantly prevented.When most cancer patients are found in addition, in middle and advanced stage, especially to shifting the patient of diffusion, cannot operate in fact; And radiotherapy chemotherapy has serious toxic and side effects to immunologic function, a hemopoietic function and human body system organ.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of cancer, by taking, can improve patient immunity, tranquillizing and allaying excitement, reducing swelling and alleviating pain, promoting of the circulation of QI and removing the obstruction in the collaterals, progressively dwindle lump, reach and alleviate patient suffering, improve life quality, the object of life-saving.
For reaching above-mentioned technical purpose, the present invention realizes by the following technical solutions:
A kind of Chinese medicine for the treatment of cancer, the raw material that comprises following portions by weight is prepared from: 5 ~ 15 parts of Rhizoma Sparganii, 3 ~ 10 parts of Radix Sophorae Tonkinensiss, 5 ~ 20 parts of Radix Salviae Miltiorrhizaes, 5 ~ 20 parts of Radix Scrophulariae, 9 ~ 20 parts of Radix Adenophorae (Radix Glehniae), 9 ~ 20 parts of Radix Codonopsis, 3 ~ 15 parts of the Radixs Angelicae Dahuricae, 5 ~ 20 parts of Radix Angelicae Sinensis, 6 ~ 20 parts of Radix Paeoniae Rubra, 3 ~ 15 parts of Radix Curcumaes, 3 ~ 15 parts of Radix Scutellariae, 9 ~ 20 parts, Poria, 5 ~ 15 parts of Rhizoma Curcumae, 5 ~ 15 parts of Bulbus Fritillariae Thunbergii, 3 ~ 15 parts of Semen Impatientis, 9 ~ 20 parts of Herba Taraxacis, 5 ~ 20 parts of Cortex Moutans, 3 ~ 10 parts, Cinnabaris, 3 ~ 15 parts of eupolyphaga, 5 ~ 20 parts of Oletum Trogopteroris, 3 ~ 15 parts, Flos Carthami, 3 ~ 15 parts of Cordyceps, 5 ~ 20 parts of Squama Maniss, 3 ~ 15 parts of the Radix Aucklandiae, 3 ~ 16 parts of Rhizoma Corydalis, 3 ~ 15 parts of Hirudos, 5 ~ 20 parts of LUMBRICUS, 5 ~ 20 parts of Radix Platycodoniss.
According to the plus-minus symptomatic therapy of Chinese medicine, according to situations such as patient's body constitution and diseases, above-mentioned every taste raw material of Chinese medicine can be adjusted in the umber providing, and gets suitable numerical value to reach best therapeutic effect.
Further, the raw material that comprises following portions by weight is prepared from: 10 parts of Rhizoma Sparganii, 5 parts of Radix Sophorae Tonkinensiss, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Scrophulariae, 10 parts of Radix Adenophorae (Radix Glehniae), 10 parts of Radix Codonopsis, 8 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 8 parts of Radix Curcumaes, 8 parts of Radix Scutellariae, 12 parts, Poria, 12 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 12 parts of Herba Taraxacis, 10 parts of Cortex Moutans, 6 parts, Cinnabaris, 12 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 10 parts of Squama Maniss, 8 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 8 parts of Hirudos, 10 parts of LUMBRICUS, 10 parts of Radix Platycodoniss.
Further, the raw material that comprises following portions by weight is prepared from: 10 parts of Rhizoma Sparganii, 6 parts of Radix Sophorae Tonkinensiss, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of Radix Scrophulariae, 14 parts of Radix Adenophorae (Radix Glehniae), 14 parts of Radix Codonopsis, 9 parts of the Radixs Angelicae Dahuricae, 12 parts of Radix Angelicae Sinensis, 13 parts of Radix Paeoniae Rubra, 9 parts of Radix Curcumaes, 9 parts of Radix Scutellariae, 14 parts, Poria, 10 parts of Rhizoma Curcumae, 10 parts of Bulbus Fritillariae Thunbergii, 9 parts of Semen Impatientis, 14 parts of Herba Taraxacis, 12 parts of Cortex Moutans, 6 parts, Cinnabaris, 9 parts of eupolyphaga, 12 parts of Oletum Trogopteroris, 9 parts, Flos Carthami, 9 parts of Cordyceps, 12 parts of Squama Maniss, 9 parts of the Radix Aucklandiae, 9 parts of Rhizoma Corydalis, 9 parts of Hirudos, 12 parts of LUMBRICUS, 12 parts of Radix Platycodoniss.
Further, the raw material that comprises following portions by weight is prepared from: 12 parts of Rhizoma Sparganii, 8 parts of Radix Sophorae Tonkinensiss, 14 parts of Radix Salviae Miltiorrhizaes, 14 parts of Radix Scrophulariae, 15 parts of Radix Adenophorae (Radix Glehniae), 15 parts of Radix Codonopsis, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 10 parts of Radix Curcumaes, 10 parts of Radix Scutellariae, 15 parts, Poria, 10 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 15 parts of Herba Taraxacis, 13 parts of Cortex Moutans, 8 parts, Cinnabaris, 8 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 14 parts of Squama Maniss, 10 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 10 parts of Hirudos, 14 parts of LUMBRICUS, 14 parts of Radix Platycodoniss.
The selected raw material pharmacology analysis of the present invention:
The effect of Rhizoma Sparganii: removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.The effect of Radix Sophorae Tonkinensis: heat-clearing and toxic substances removing, detumescence sore-throat relieving.The effect of Radix Salviae Miltiorrhizae: there is blood circulation and promoting silt, removing heat from blood quench, mind tranquilizing and the heart calming.The effect of Radix Scrophulariae: heat-clearing and toxic substances removing, hard masses softening and resolving.The effect of Radix Adenophorae (Radix Glehniae): the merit with Yin-nourishing and body fluid promoting, clearing away heat and cooling blood.The effect of Radix Codonopsis: invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.The effect of the Radix Angelicae Dahuricae: dispel the wind, dampness, detumescence, pain relieving.The effect of Radix Angelicae Sinensis: enrich blood invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.The effect of Radix Paeoniae Rubra: clearing away heat and cooling blood, stimulate the menstrual flow and the effect of liver heat removing eliminating carbuncle, antithrombotic forms.The effect of Radix Curcumae: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.The effect of Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication, removing heat from blood and promoting blood circulation.The effect of Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming.The effect of Rhizoma Curcumae: circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving.The effect of Bulbus Fritillariae Thunbergii: heat clearing away eliminating stagnation, preventing phlegm from forming and stopping coughing.Shorttempered effect: removing blood stasis softening the hard mass, removing food stagnancy.The effect of Herba Taraxaci: heat-clearing and toxic substances removing, Detoxicating food-poisoning and detumescence.The effect of Cortex Moutan: clearing away heat and cooling blood; Promoting blood circulation to remove blood stasis.The effect of Cinnabaris: tranquilizing mind, heat-clearing and toxic substances removing, improving eyesight.The effect of eupolyphaga: consumer edema, relieves internal heat.The effect of Oletum Trogopterori: eliminating stasis to stop pain.The effect of Flos Carthami: promoting blood circulation to restore menstrual flow, go the pain relieving of becoming silted up.The effect of Cordyceps: invigorating the lung and the kidney, hemostasis and phlegm, enhancing immunity.The effect of Squama Manis: eliminating stasis and resolving masses, eliminating carbuncle evacuation of pus.The effect of the Radix Aucklandiae: circulation of qi promoting, in tune, relieves the pain.The effect of Rhizoma Corydalis: promoting flow of QI and blood pain relieving.The effect of Hirudo: blood circulation promoting and blood stasis dispelling.The effect of LUMBRICUS: heat clearing away, suppressing the hyperactive liver, Zhichuan, dredging collateral.Effect lung qi dispersing, the sore-throat relieving of Radix Platycodonis, eliminate the phlegm, evacuation of pus.
The compatibility of raw material of the present invention is rationally unique, the combination of above raw material can heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain, promoting of the circulation of QI and removing the obstruction in the collaterals, improve patient's immunity, especially cloudy thanks to patient with advanced cancer blood depletion, deficiency of lung-YIN, and deficiency of both QI and YIN after cancer operation, or the dry person of the withered liquid in Tianjin who causes because of radiotherapy impairment of YIN, there is good curative effect.
The Chinese medicine for the treatment of cancer provided by the invention is forefathers' secret recipe.After research repeatedly, refinement, optimization, be applied to clinical practice and obtained good effect, remarkable for treatment kinds cancer effect.By taking Chinese medicine of the present invention, can improve patient's immunity, strengthen the ability that human leukocytes is killed cancerous cell; And there is tonification internal organs, tranquillizing and allaying excitement, reducing swelling and alleviating pain, promoting of the circulation of QI and removing the obstruction in the collaterals, progressively dwindle lump, reach and alleviate patient suffering, improve life quality, the effect of life-saving.By the lifting of patient's immunity, can rely on self-resistance to eliminate cancerous cell.Cancer patient takes the effect that this medicine has played prevention of recurrence at operation, chemicotherapy later.After being taken to this medicine, patient with advanced cancer can reduce misery, extending life.Early stage cancer patient takes this medicine, also has good curative effect.
Utilize the conventional method of Chinese drug preparation, the present invention treats the Chinese medicine of cancer can make decocting decoction, electuary, pill, tablet or capsule etc.
The curative effect of Chinese medicine of the present invention is described below by clinical data:
1, clinical observation
Patient 200 people that are diagnosed as cancer through hospital accepted and follow the tracks of altogether for medical treatment by Chinese medicine of the present invention from calendar year 2001 to 2013 year, age 40 examples that are 30 ~ 40 years old wherein, and 60 examples of 40 ~ 50 years old, 50 years old 100 above example, M-F is 3:1.Collect simultaneously and followed the tracks of 200 cancer patients that use chemotherapeutics treatment group as a comparison, take the medicines such as mitomycin, cisplatin, amycin.
2, Therapeutic Method
Instructions of taking: the electuary that adopts Chinese medicine of the present invention to make, patient with severe symptoms takes twice general every day, and after stable disease, clothes on the one once, generally need be taken one to three course for the treatment of, and be three months each course for the treatment of.Inactive other drug during treatment.Patient does relevant inspection itemized record before and after treatment.
Dietetic contraindication: should not simultaneously take with other Chinese medicine dieting wine, maror while taking.
3, criterion of therapeutical effect:
Remarkable: after drug administration, physical recovery; Process B ultrasonic, CT examination: tumor is obviously dwindled or disappeared, and laboratory indexes obviously declines.
Effective: after drug administration, symptom is improved, and tumor examination does not develop.
Invalid: after drug administration, to take front without improving.
4, efficacy result:
| Total number of persons | Remarkable number | Efficiently individual quantity | Invalid number | Effective percentage | |
| The present invention | 200 | 100 | 60 | 40 | 80% |
| Contrast groups | 200 | 50 | 50 | 100 | 50% |
5, some cases data:
Case 1, king so-and-so, female, 37 years old, hospital diagnosis was malignant brain tumor, at Beijing Navy General Hospital through after two operations treatment, disease relapse.Patient starts to take Chinese medicine of the present invention August 31 calendar year 2001, takes continuously after 9 months, gets back to Beijing check, and result is normal, has no lump.Health is good so far in December, 2002 drug withdrawal for patient.
Case 2, Lee so-and-so, man, 65 years old, bladder cancer, spread after operative treatment, stops chemicotherapy, and started to take Chinese medicine of the present invention in May, 2006, took continuously the check of 6 Yue Hou，Qu hospitals no abnormal; Remove every year afterwards a no abnormality seen of hospital's check, health is good so far.
Case 3, Xu so-and-so, man, 52 years old, esophageal carcinoma, operative treatment, had a medical check-up and found diffusion on May 18th, 2007 on June 2nd, 2006, occurred crisis sign, dysphagia, can not take food, operation for the second time, abandoning cure can not be done by hospital.Take after Chinese medicine of the present invention January 14 26 days to 2008 May in 2007, and diet, by liquid food, half liquid food, is restored very soon, and the state of an illness progressively takes a turn for the better, after return to one's perfect health.
Case 4, the Qin so-and-so, man, 35 years old, be diagnosed as right lower limb soft tissue sarcoma at PLA's 401 examination in hospital in June, 2010, qualitative is malignant fibrohistiocytoma, in tumor tissue blood vessel, see tumor bolt, carry out after amputation, chemotherapy, still occur soon cancerous cell diffusion, after proceed to Qingdao City Tumour Hospital treatment about one week, allow it leave hospital and go home to carry out recuperation in late period.Patient starts to take Chinese medicine of the present invention on August 7th, 2010, takes continuously the check of three Ge Yuehoudao hospitals, and relevant thrombosis index normal, continues to take after six months and check once again, and check result is completely normal, and health is good.
Case 5, Xu so-and-so, female, 37 years old, ovarian cancer, the 301 hospital surgicals treatments of 2010 Nian Beijing PLA, recurrence after four months, three Ling Yi hospitals check its original place, island radiotherapy ，Hou You Qingdao Municipal Hospitals of turning green of relief and carry out operative treatment for the second time.Operation starts to take Chinese medicine to 2012 of the present invention drug withdrawal in 30, on Mays on April 4th, 2011 after being introduced, June, to hospital, checks, and check result is normal, and health is good so far.
Case 6, Lin, man, 81 years old, advanced lung cancer, unconditionally operation, hospital's abandoning cure, allows it go home to recuperate.After starting to take Chinese medicine of the present invention on April 10th, 2012 upon somebody's introduction, patient feels good, and energy muscle power starts to recover, and takes continuously successful after three courses for the treatment of, follows up a case by regular visits to, and health is good.
Case 7, Tang so-and-so, man, 55 years old, gastric cancer, carried out after the large portion of stomach resection operation in August, 2011, in May, 2012 recurrence, extensively transferred to liver, lymph, patient is weak, tired mind is off one's feed, sb.'s illness took a turn for the worse, hospital does not receive.Since on May 30th, 2012, take after Chinese medicine of the present invention upon somebody's introduction, patient feels good, and life, diet progressively recover normally, and health is good so far.
Case 8, checks and is diagnosed as pulmonary carcinoma, left hilar shadow increases, and sees big or small about 34*47mm lump around, the multiple lymphadenectasis in position such as two lungs, vertical diaphragm in so-and-so ，Nan ，50Sui， Heilongjiang Province land-reclaimable general bureau hospital general the second tumour hospital.Because considering, shift, patient determines to abandon operative treatment.Start to take Chinese medicine of the present invention in March, 2013, checked left lung lump substantially disappear to June 19, patient is in high spirits, and livelihood restoration is normal, now rehabilitation.
6, clinical analysis
Chinese medicine clinical verification satisfactory effect of the present invention, can improve the immunologic function of body, regulates body equilibrium between yin and yang, to the treatment of cancer play relieving the pain caused by diseases, lump reduces or the effect that disappears.Chinese medicine of the present invention is applicable to effective treatment in each stage of cancer, and without significantly side effect, after patient's drug administration, to routine examinations such as patient's hepatic and renal function, routine blood test, defecation, all do not find the ANOMALOUS VARIATIONS causing because taking Chinese medicine of the present invention, clinic is promoted the use of.
The specific embodiment
In order better to understand and to implement the present invention, below in conjunction with embodiment, further illustrate.
Embodiment 1:
Treating a Chinese medicine for cancer, is that the raw material by following portions by weight is prepared from: 10 parts of Rhizoma Sparganii, 5 parts of Radix Sophorae Tonkinensiss, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Scrophulariae, 10 parts of Radix Adenophorae (Radix Glehniae), 10 parts of Radix Codonopsis, 8 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 8 parts of Radix Curcumaes, 8 parts of Radix Scutellariae, 12 parts, Poria, 12 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 12 parts of Herba Taraxacis, 10 parts of Cortex Moutans, 6 parts, Cinnabaris, 12 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 10 parts of Squama Maniss, 8 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 8 parts of Hirudos, 10 parts of LUMBRICUS, 10 parts of Radix Platycodoniss.
Above-mentioned each single raw material is crushed to 120 orders with pulverizer, then according to aforementioned proportion, gets each raw material after pulverizing, be fully mixed and made into pulverous electuary.
Embodiment 2:
Treating a Chinese medicine for cancer, is that the raw material by following portions by weight is prepared from: by 10 parts of Rhizoma Sparganii, 6 parts of Radix Sophorae Tonkinensiss, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of Radix Scrophulariae, 14 parts of Radix Adenophorae (Radix Glehniae), 14 parts of Radix Codonopsis, 9 parts of the Radixs Angelicae Dahuricae, 12 parts of Radix Angelicae Sinensis, 13 parts of Radix Paeoniae Rubra, 9 parts of Radix Curcumaes, 9 parts of Radix Scutellariae, 14 parts, Poria, 10 parts of Rhizoma Curcumae, 10 parts of Bulbus Fritillariae Thunbergii, 9 parts of Semen Impatientis, 14 parts of Herba Taraxacis, 12 parts of Cortex Moutans, 6 parts, Cinnabaris, 9 parts of eupolyphaga, 12 parts of Oletum Trogopteroris, 9 parts, Flos Carthami, 9 parts of Cordyceps, 12 parts of Squama Maniss, 9 parts of the Radix Aucklandiae, 9 parts of Rhizoma Corydalis, 9 parts of Hirudos, 12 parts of LUMBRICUS, 12 parts of Radix Platycodoniss.
Above-mentioned each single raw material is crushed to 120 orders with pulverizer, then according to aforementioned proportion, gets each raw material after pulverizing, be fully mixed and made into capsule.
Embodiment 3:
Treating a Chinese medicine for cancer, is that the raw material by following portions by weight is prepared from: by 12 parts of Rhizoma Sparganii, 8 parts of Radix Sophorae Tonkinensiss, 14 parts of Radix Salviae Miltiorrhizaes, 14 parts of Radix Scrophulariae, 15 parts of Radix Adenophorae (Radix Glehniae), 15 parts of Radix Codonopsis, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 10 parts of Radix Curcumaes, 10 parts of Radix Scutellariae, 15 parts, Poria, 10 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 15 parts of Herba Taraxacis, 13 parts of Cortex Moutans, 8 parts, Cinnabaris, 8 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 14 parts of Squama Maniss, 10 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 10 parts of Hirudos, 14 parts of LUMBRICUS, 14 parts of Radix Platycodoniss.
Above-mentioned each single raw material is crushed to 120 orders with pulverizer, then according to aforementioned proportion, gets each raw material after pulverizing, be fully mixed and made into pulverous electuary.
Claims (4)
1. a Chinese medicine for the treatment of cancer, it is characterized in that, the raw material that comprises following portions by weight is prepared from: 5 ~ 15 parts of Rhizoma Sparganii, 3 ~ 10 parts of Radix Sophorae Tonkinensiss, 5 ~ 20 parts of Radix Salviae Miltiorrhizaes, 5 ~ 20 parts of Radix Scrophulariae, 9 ~ 20 parts of Radix Adenophorae (Radix Glehniae), 9 ~ 20 parts of Radix Codonopsis, 3 ~ 15 parts of the Radixs Angelicae Dahuricae, 5 ~ 20 parts of Radix Angelicae Sinensis, 6 ~ 20 parts of Radix Paeoniae Rubra, 3 ~ 15 parts of Radix Curcumaes, 3 ~ 15 parts of Radix Scutellariae, 9 ~ 20 parts, Poria, 5 ~ 15 parts of Rhizoma Curcumae, 5 ~ 15 parts of Bulbus Fritillariae Thunbergii, 3 ~ 15 parts of Semen Impatientis, 9 ~ 20 parts of Herba Taraxacis, 5 ~ 20 parts of Cortex Moutans, 3 ~ 10 parts, Cinnabaris, 3 ~ 15 parts of eupolyphaga, 5 ~ 20 parts of Oletum Trogopteroris, 3 ~ 15 parts, Flos Carthami, 3 ~ 15 parts of Cordyceps, 5 ~ 20 parts of Squama Maniss, 3 ~ 15 parts of the Radix Aucklandiae, 3 ~ 16 parts of Rhizoma Corydalis, 3 ~ 15 parts of Hirudos, 5 ~ 20 parts of LUMBRICUS, 5 ~ 20 parts of Radix Platycodoniss.
2. the Chinese medicine for the treatment of cancer according to claim 1, it is characterized in that, the raw material that comprises following portions by weight is prepared from: 10 parts of Rhizoma Sparganii, 5 parts of Radix Sophorae Tonkinensiss, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Scrophulariae, 10 parts of Radix Adenophorae (Radix Glehniae), 10 parts of Radix Codonopsis, 8 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 8 parts of Radix Curcumaes, 8 parts of Radix Scutellariae, 12 parts, Poria, 12 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 12 parts of Herba Taraxacis, 10 parts of Cortex Moutans, 6 parts, Cinnabaris, 12 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 10 parts of Squama Maniss, 8 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 8 parts of Hirudos, 10 parts of LUMBRICUS, 10 parts of Radix Platycodoniss.
3. the Chinese medicine for the treatment of cancer according to claim 1, it is characterized in that, the raw material that comprises following portions by weight is prepared from: 10 parts of Rhizoma Sparganii, 6 parts of Radix Sophorae Tonkinensiss, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts of Radix Scrophulariae, 14 parts of Radix Adenophorae (Radix Glehniae), 14 parts of Radix Codonopsis, 9 parts of the Radixs Angelicae Dahuricae, 12 parts of Radix Angelicae Sinensis, 13 parts of Radix Paeoniae Rubra, 9 parts of Radix Curcumaes, 9 parts of Radix Scutellariae, 14 parts, Poria, 10 parts of Rhizoma Curcumae, 10 parts of Bulbus Fritillariae Thunbergii, 9 parts of Semen Impatientis, 14 parts of Herba Taraxacis, 12 parts of Cortex Moutans, 6 parts, Cinnabaris, 9 parts of eupolyphaga, 12 parts of Oletum Trogopteroris, 9 parts, Flos Carthami, 9 parts of Cordyceps, 12 parts of Squama Maniss, 9 parts of the Radix Aucklandiae, 9 parts of Rhizoma Corydalis, 9 parts of Hirudos, 12 parts of LUMBRICUS, 12 parts of Radix Platycodoniss.
4. the Chinese medicine for the treatment of cancer according to claim 1, it is characterized in that, the raw material that comprises following portions by weight is prepared from: 12 parts of Rhizoma Sparganii, 8 parts of Radix Sophorae Tonkinensiss, 14 parts of Radix Salviae Miltiorrhizaes, 14 parts of Radix Scrophulariae, 15 parts of Radix Adenophorae (Radix Glehniae), 15 parts of Radix Codonopsis, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 10 parts of Radix Curcumaes, 10 parts of Radix Scutellariae, 15 parts, Poria, 10 parts of Rhizoma Curcumae, 12 parts of Bulbus Fritillariae Thunbergii, 10 parts of Semen Impatientis, 15 parts of Herba Taraxacis, 13 parts of Cortex Moutans, 8 parts, Cinnabaris, 8 parts of eupolyphaga, 15 parts of Oletum Trogopteroris, 10 parts, Flos Carthami, 12 parts of Cordyceps, 14 parts of Squama Maniss, 10 parts of the Radix Aucklandiae, 10 parts of Rhizoma Corydalis, 10 parts of Hirudos, 14 parts of LUMBRICUS, 14 parts of Radix Platycodoniss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310530442.2A CN103520659B (en) | 2013-11-01 | 2013-11-01 | Traditional Chinese medicine for treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310530442.2A CN103520659B (en) | 2013-11-01 | 2013-11-01 | Traditional Chinese medicine for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520659A true CN103520659A (en) | 2014-01-22 |
| CN103520659B CN103520659B (en) | 2015-05-20 |
Family
ID=49923246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310530442.2A Active CN103520659B (en) | 2013-11-01 | 2013-11-01 | Traditional Chinese medicine for treating cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520659B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258309A (en) * | 2014-10-22 | 2015-01-07 | 陈洁 | Traditional Chinese medicine composition for treating cancers |
| CN104383464A (en) * | 2014-12-10 | 2015-03-04 | 高田田 | Traditional Chinese medicine composition for treating ovarian cancer |
| CN108785498A (en) * | 2018-09-03 | 2018-11-13 | 广州暨南生物医药研究开发基地有限公司 | A kind of Chinese medicine composition and application thereof with antitumaous effect |
| CN110101825A (en) * | 2019-06-25 | 2019-08-09 | 张家港市力锦源科技发展有限公司 | A kind of Chinese medicine for the treatment of cancer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1219405A (en) * | 1997-12-10 | 1999-06-16 | 黄钰孙 | Aifukang capsule for curing cancer |
| CN101152282A (en) * | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating upper limb swelling after breast cancer operation |
-
2013
- 2013-11-01 CN CN201310530442.2A patent/CN103520659B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1219405A (en) * | 1997-12-10 | 1999-06-16 | 黄钰孙 | Aifukang capsule for curing cancer |
| CN101152282A (en) * | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating upper limb swelling after breast cancer operation |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258309A (en) * | 2014-10-22 | 2015-01-07 | 陈洁 | Traditional Chinese medicine composition for treating cancers |
| CN104383464A (en) * | 2014-12-10 | 2015-03-04 | 高田田 | Traditional Chinese medicine composition for treating ovarian cancer |
| CN108785498A (en) * | 2018-09-03 | 2018-11-13 | 广州暨南生物医药研究开发基地有限公司 | A kind of Chinese medicine composition and application thereof with antitumaous effect |
| CN110101825A (en) * | 2019-06-25 | 2019-08-09 | 张家港市力锦源科技发展有限公司 | A kind of Chinese medicine for the treatment of cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520659B (en) | 2015-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102847064A (en) | Chinese herbal medicine used for inhibition of malignant tumor metastasis | |
| CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| WO2012139314A1 (en) | Chinese herbal medicinal composition for treating cancer | |
| CN103520659B (en) | Traditional Chinese medicine for treating cancer | |
| CN108785616A (en) | It strengthens the body resistance to consolidate the constitution Nude mice | |
| CN103920034B (en) | Chinese medicine composition and the method for making of the side reaction of ameliorate tumor chemotherapy of patients | |
| CN101385843A (en) | Nano medicine magnet therapy plaster for relieving the swelling and easing pain | |
| CN102198226A (en) | Chinese herbal medicine composition for treating cancer | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN103356868A (en) | Chinese medicinal capsule for treatment of psoriasis | |
| CN102327512B (en) | Traditional Chinese medicine formula for treating prostatitis | |
| CN104288624A (en) | Pharmaceutical composition and application thereof | |
| CN101366896B (en) | Traditional Chinese medicine for treating chronic prostatitis and preparation method thereof | |
| CN102805844A (en) | Medicine for treating liver cancer | |
| CN104147269A (en) | Traditional Chinese medicine used for treating systemic lupus erythematosus | |
| CN103127411B (en) | Traditional Chinese medicine used for treating urinary tract infection disease | |
| CN104083591B (en) | A kind of external stype and preparation method for the treatment of hemorrhoid | |
| CN104258309A (en) | Traditional Chinese medicine composition for treating cancers | |
| CN104645247B (en) | A kind of Chinese medicine preparation for treating hepatolenticular degeneration and preparation method thereof | |
| CN105902885A (en) | Traditional Chinese medicine for treatment of lung cancer | |
| CN105327295A (en) | Capsules for treating hepatitis and preparing method thereof | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN105663906A (en) | Traditional Chinese medicinal composition for treating rectal cancer | |
| CN105250911A (en) | Traditional Chinese medicine preparation for preventing and treating cancer and preparation method thereof | |
| CN104721572B (en) | A kind of Chinese medicine for treating chronic colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yuan Benjun Inventor after: Tang Shuguang Inventor after: Lv Zhiqiang Inventor after: Wang Jiaxiang Inventor before: Yuan Benjun Inventor before: Tang Shuguang Inventor before: Lv Zhiqiang Inventor before: Wang Jiaxiang |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151221 Address after: Da Sha Road, Sifang District of Qingdao city of Shandong Province, No. 26 266000 Patentee after: Yuan Benjun Address before: Shinan District 266000 Shandong city of Qingdao province Nantong Road 2, building 8, unit 1, 501 households Patentee before: Tang Shuguang |